Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder in children: A case report and review of the literature

被引:4
|
作者
Plumptre, Isabella R. [1 ]
Said, Jordan T. [2 ,3 ]
Sheu Song, Johanna [2 ]
Corey, Kristen [3 ,4 ]
LeBoeuf, Nicole R. [3 ,4 ,5 ]
机构
[1] Imperial Coll Healthcare NHS Trust, London, England
[2] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Boston Childrens Hosp, Dept Dermatol, Boston, MA USA
[5] Dana Farber Canc Inst, Ctr Cutaneous Oncol, 375 Longwood Ave, Boston, MA 02115 USA
关键词
lymphoproliferative disorder; PCSM-TCLPD; pediatric cutaneous oncology; pediatric oncology; peripheral T-cell lymphoproliferative disorder; primary cutaneous CD4(+) small; medium T-cell lymphoproliferative disorder; LYMPHOMA; MULTICENTER; CD4+SMALL; PATIENT; SERIES;
D O I
10.1002/pbc.29862
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary cutaneous CD4(+) small/medium T-cell lymphoproliferative disorder (PCSM-TCLPD) is a rare benign lymphoproliferative disorder, recently redefined by the 2016 World Health Organization classification of lymphoid neoplasms. In adults, PCSM-TCLPD responds well to monotherapy with surgical excision or local radiation, with or without topical/injected corticosteroids; in contrast, PCSM-TCLPD has only rarely been reported in children, in whom treatments favored in adults may be non-optimal. We present a 14-year-old male with PCSM-TCLPD on the forehead, who achieved complete remission following biopsy, topical corticosteroids, and surgical excision. We also review all literature-reported cases of pediatric PCSM-TCLPD, emphasizing the disorder's benign nature and treatment responsiveness in children.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4+ small or medium T-cell lymphoproliferative disorder
    Oschlies, Ilske
    Kock, Katharina
    Wueseke, Thomas
    Richter, Julia
    Koch, Karoline
    Wehkamp, Ulrike
    Klapper, Wolfram
    HISTOPATHOLOGY, 2023, 82 (03) : 485 - 494
  • [42] Primary cutaneous CD4+small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review
    Salah, Eman
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 (02): : 123 - 137
  • [43] Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder in a woman successfully treated with intralesional interleukin injection and occlusive corticosteroid
    Jiang, Yuyang
    Liu, Donghua
    Alnasri, Alya
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2020, 86 (06): : 726 - 729
  • [44] Treatment of primary cutaneous CD4+small to medium pleomorphic T-cell lymphoproliferative disorder with the use of intralesional triamcinolone
    Mckissack, Sterling
    Ritchie, Simon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB302 - AB302
  • [45] A case of primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma
    Suchun Hou
    Xiaoming Liu
    Junru Liu
    Zhenying Zhang
    Bin Wang
    Changxu Han
    European Journal of Dermatology, 2016, 26 : 629 - 630
  • [46] Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features
    Bakr, Farrah
    Wain, E. Mary
    Barlow, Richard
    Robson, Alistair
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2021, 43 (12) : E204 - E212
  • [47] Controversies and Considerations in the Diagnosis of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoma
    Lan, Thanh T. Ha
    Brown, Noah A.
    Hristov, Alexandra C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (10) : 1307 - 1318
  • [48] Primary Cutaneous CD4+ Small- to Medium-Sized Pleomorphic T-Cell Lymphoma: Report of a Case With Spontaneous Resolution
    Messeguer, F.
    Gimeno, E.
    Agusti-Mejias, A.
    San Juan, J.
    ACTAS DERMO-SIFILIOGRAFICAS, 2011, 102 (08): : 636 - 638
  • [49] CD27/CD70 pathway activation in primary cutaneous CD4+small/medium T-cell lymphoproliferative disorder
    Richter, Julia
    Oschlies, Ilske
    Kock, Katharina
    Wueseke, Thomas
    Haag, Jochen
    Koch, Karoline
    Klapper, Wolfram
    JOURNAL OF PATHOLOGY, 2024, 262 (02): : 189 - 197
  • [50] Primary cutaneous lymphoproliferations in the gray zone between marginal zone lymphoma and CD4+ small/medium T-cell lymphoproliferative disease
    Palos, Kata
    Szakonyi, Jozsef
    Csomor, Judit
    Gremsperger, Asa
    Zajta, Erik
    Marschalko, Marta
    Szepesi, Agota
    JOURNAL OF CUTANEOUS PATHOLOGY, 2024, 51 (11) : 868 - 875